• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Clinical Data

Close-up of human eye
Biotech

Opus sets sights on FDA talks after posting gene therapy data

Opus Genetics shared data on its gene therapy in kids with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps.
Nick Paul Taylor Sep 30, 2025 9:15am
weight loss scale weigh measure tape obesity overweight

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

Sep 30, 2025 6:40am
RSV

Enanta sees RSV drug fail phase 2b but finds positives

Sep 29, 2025 8:05am
Moon Lake

MoonLake stock sinks as high placebo rate eclipses ph. 3 results

Sep 29, 2025 8:05am
Cartoon of businessmen standing around a broken target

Harmony's pivotal trial flops as placebo response causes discord

Sep 24, 2025 9:35am
business targets illustration

uniQure plans FDA push after Huntington's gene therapy trial win

Sep 24, 2025 9:20am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings